Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
04/25/2002 | US20020048559 Copolymer and process for preparing the same |
04/25/2002 | US20020048558 Topical delivery systems for active agents |
04/25/2002 | US20020048551 Nutritional supplements that are encapsulated in lipid vesicles for administration as an aerosol or liquid droplet spray. |
04/25/2002 | US20020047058 At least one composition of media bodies provides fragments of milling media bodies that are retained with the milled solid substrate particles in the form of a synergetic commixture produced in the milling process. |
04/25/2002 | US20020046750 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
04/25/2002 | DE10146009A1 Material for producing fibrinolytic and/or antibacterial products comprises a partially dehydrated molecular sieve loaded with active agent(s) and incorporated into a tissue-compatible matrix |
04/25/2002 | DE10049147A1 Haarwachsprodukt mit Wachsen, nicht-flüchtigen Ölen und flüchtigen, hydrophoben Stoffen Hair wax product with waxes, non-volatile oils and volatile, hydrophobic substances |
04/25/2002 | DE10045343A1 Augenarzneimittel Eye medicines |
04/25/2002 | DE10034673C1 Dermales Applikationssystem für Aminolävulinsäure und seine Verwendung Dermal application system for aminolevulinic acid and its use |
04/25/2002 | CA2689856A1 Composition and method for stable injectable liquids |
04/25/2002 | CA2464092A1 Electroprocessing in drug delivery and cell encapsulation |
04/25/2002 | CA2426697A1 Method for making very fine particles consisting of a principle inserted in a host molecule |
04/25/2002 | CA2426175A1 Stable oral formulation containing benzimidazole derivative |
04/25/2002 | CA2426083A1 Use of hyaluronic acid derivatives for inhibiting inflammatory arthritis |
04/25/2002 | CA2425900A1 Novel medicinal herbal composition for treating liver diseases and hiv |
04/25/2002 | CA2425831A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor |
04/25/2002 | CA2425310A1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
04/25/2002 | CA2425196A1 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes |
04/25/2002 | CA2424345A1 Liposomal formulation of mitoxantrone |
04/25/2002 | CA2423469A1 Methods and products related to pulmonary delivery of polysaccharides |
04/24/2002 | EP1199079A2 Use of plant extract for treatment and prevention of sore throats |
04/24/2002 | EP1199077A1 Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers |
04/24/2002 | EP1199073A1 Aminoethanesulfonic acid-containing preparations |
04/24/2002 | EP1198995A1 Anti-stress composition for incorporation in nutritional carriers |
04/24/2002 | EP1198570A1 Monomeric protein of the tgf-beta family |
04/24/2002 | EP1198494A1 Preparations that are devoid of cross-linking agents |
04/24/2002 | EP1198490A1 Neutral lipopolymer and liposomal compositions containing same |
04/24/2002 | EP1198488A1 Biodegradable block copolymers with modifiable surface |
04/24/2002 | EP1198322A1 Apparatus and methods for alternating laser treatment of pharmaceutical dispensers |
04/24/2002 | EP1198256A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery |
04/24/2002 | EP1198233A1 Sulfonamide and sulfamide substituted imidazoquinolines |
04/24/2002 | EP1198228A2 Release of poorly soluble agents |
04/24/2002 | EP1198227A1 Method for producing quickly decomposable solid pharmaceutical preparations |
04/24/2002 | EP1198226A1 Mesalazine controlled release oral pharmaceutical compositions |
04/24/2002 | EP1198225A1 Epothilone compositions |
04/24/2002 | EP1198224A1 Formulations of steroid solutions for inhalatory administration |
04/24/2002 | EP1198223A2 Ophthalmic composition comprising ketotifen |
04/24/2002 | EP0853494B1 Oil-water emulsifiers |
04/24/2002 | EP0818992B1 Procedure for encapsulating nsaids |
04/24/2002 | EP0801559B1 Process for the preparation of oral dosage-forms containing a beta-lactam antibiotic |
04/24/2002 | EP0789557B1 Propellant mixture for aerosol formulation |
04/24/2002 | EP0743860B1 Preparation of hollow microcapsules |
04/24/2002 | EP0621877B2 Esters of pectic and pectinic acid |
04/24/2002 | CN2487379Y Special machine for making stype |
04/24/2002 | CN1346393A Adhesives |
04/24/2002 | CN1346363A The novel antisense-oligos with better stability and antisense effect |
04/24/2002 | CN1346360A Phosphoramidate, and mono-di, and tri-phosphate esters of (1R, cis)-4-(6-amino-9H-purin-9-YL)-2-cyclopentene-1-methanol as antiviral agents |
04/24/2002 | CN1346356A 治疗性的核苷化合物 Therapeutic nucleoside compound |
04/24/2002 | CN1346344A Substituted 2-aminobenzamide caspase ihibitors and the use thereof |
04/24/2002 | CN1346283A External coated chewing gum products |
04/24/2002 | CN1346276A Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria |
04/24/2002 | CN1346274A Formulation comprising testosteron undecanoate and castor oil |
04/24/2002 | CN1346273A Use of sex hormones to obtain a nasal pharmaceutical composition that is useful in the treatment of undesirable uterine bleeding |
04/24/2002 | CN1346270A Compositions having improved stability |
04/24/2002 | CN1346265A Preparations for percutaneous absorption |
04/24/2002 | CN1346262A Antimicrobial wipes which provide improved immediate germ reduction |
04/24/2002 | CN1346257A Liquid dispersion polymer composition, their preparation and their use |
04/24/2002 | CN1346252A Prolonged release bioadhesive vaginal gel dosage form |
04/24/2002 | CN1345597A Extract of free anthraquinone extracted from rhubarb and preparation process thereof |
04/24/2002 | CN1345595A Aerosol for oral cavity health care |
04/24/2002 | CN1345592A Productive technology for producing Jiatong powder injection |
04/24/2002 | CN1345588A No-stinking fish-oil composite micro-capsule and preparation process |
04/24/2002 | CN1345586A Medicine for relieving itching and detumescence |
04/24/2002 | CN1345585A Process for preparing micropowder of cell rupture cable for raising Chinese medicine availability |
04/24/2002 | CN1345584A Process for preparing non-aqueous Chinese medicine compount injecta |
04/24/2002 | CN1083459C Process for preparing polymer powders redispersible in aqueous solution and prepared polymer powders |
04/24/2002 | CN1083449C Nonionic vitamin E derivatives and method for prparation thereof, and polymeric amphiphilic vesicles made therefrom |
04/24/2002 | CN1083279C Gel form of a vaccine and preparation process thereof |
04/24/2002 | CN1083277C Thrat smoothing candy made of starculia scaphigera |
04/24/2002 | CN1083275C Medicine for treating breast tuomor and carbuncle and preparation method thereof |
04/24/2002 | CN1083268C Ointment for treating burn and scald and promoting tissue regeneration |
04/24/2002 | CN1083267C Compositions of cartaegus species, medicaments and their use |
04/24/2002 | CN1083266C Total parenteral nutrition solution containing water-soluble vitamin B |
04/24/2002 | CN1083265C Improved pharmaceutical formulations containing ibuprofen and codeine |
04/24/2002 | CN1083263C Use of melatonin for treating patients suffering from drug addiction |
04/24/2002 | CN1083262C Composition of L-dopa esters |
04/24/2002 | CN1083260C Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide |
04/24/2002 | CN1083259C Trans dermal matrix system |
04/23/2002 | US6377847 Iontophoretic drug delivery device and reservoir and method of making same |
04/23/2002 | US6376657 Pharmaceutical compositions having appetite suppressant activity |
04/23/2002 | US6376644 Biodegradable polymers chain-extended by phosphates, compositions, articles and methods for making and using the same |
04/23/2002 | US6376545 Tablet |
04/23/2002 | US6376514 Piperidine-derived compounds containing a quinolyl group that inhibits p-glycoprotein transport protein activity; for treating cancer and other diseases |
04/23/2002 | US6376504 Phenethyl-5-bromopyridlythiourea (PBT) and dihydroalkoxybenzyloxopyrimidine (DBABO) derivatives exhibiting spermicidal activity |
04/23/2002 | US6376486 Methods of inhibiting sphincter incontinence |
04/23/2002 | US6376481 Solid oral dosage form comprising support having given surface area range such as silicon dioxide, a stanol ester to reduce cholesterol, and a mixed micelle surfactant system |
04/23/2002 | US6376464 That form amphipathic helices, bind lipids, form prebeta-like or hdl-like complexes, activate lcat, increase serum levels of hdl fractions, and promote cholesterol efflux, dyslipopro-teinemia, hypercholesterolemia, cardiovascular disorders |
04/23/2002 | US6376461 Sustained-release preparation |
04/23/2002 | US6376248 Peptide-enhanced transfections |
04/23/2002 | US6376242 Reduce the number of circulating platelets to low or below normal levels. |
04/23/2002 | US6376219 Amylose products as matrix former for programmed release systems, process for preparing these amylose products, and process for making programmed release systems |
04/23/2002 | US6375994 Preparation of fiber, L-glutamine and a soy derivative for the purpose of enhancement of isoflavone bioavailability |
04/23/2002 | US6375990 Iontophoretically delivering lithium |
04/23/2002 | US6375988 Drug composition with controlled drug release rate |
04/23/2002 | US6375987 Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix |
04/23/2002 | US6375986 Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate |
04/23/2002 | US6375985 System and method for producing drug-loaded microparticles |
04/23/2002 | US6375984 Aqueous-based pharmaceutical composition |
04/23/2002 | US6375983 Microencapsulated fragrances and method for preparation |
04/23/2002 | US6375982 Rapid-melt semi-solid compositions, methods of making same and method of using same |